Radiation Duration in Women with Cervical Cancer Treated with Primary Chemoradiation: A Population-Based Analysis

References

• Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340:1154–1161.
   PubMed Web of Science ®Google Scholar
• Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137–1143.
   PubMed Web of Science ®Google Scholar
• Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–1153.
   PubMed Web of Science ®Google Scholar
• Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17:1339–1348.
   PubMed Web of Science ®Google Scholar
• Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemo- therapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606–1613.
   PubMed Web of Science ®Google Scholar
• Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992;25:273–279.
   PubMed Web of Science ®Google Scholar
• Girinsky T, Rey A, Roche B, Haie C, Gerbaulet A, Randrianarivello H, et al. Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 1993;27:1051–1056.
   PubMed Web of Science ®Google Scholar
• Lanciano RM, Pajak TF, Martz K, Hanks GE. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. Int J Radiat Oncol Biol Phys 1993;25:391–397.
   PubMed Web of Science ®Google Scholar
• Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995;32:1275–1288.
   PubMed Web of Science ®Google Scholar
• Petereit DG, Sarkaria JN, Chappell R, Fowler JF, Hartmann TJ, Kinsella TJ, et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 1995;32:1301–1307.
   PubMed Web of Science ®Google Scholar
• Keane TJ, Fyles B, O'Sullivan B, Barton M, Maki E, Simm J. The effect of treatment duration on local control of squamous carcinoma of the tonsil and carcinoma of the cervix. Seminars in Radiat Oncol 1992;2(1):26–28.
   Google Scholar
• Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncologica 1988;27:131–146.
   PubMed Web of Science ®Google Scholar
• Barton MB, Keane TJ, Gadalla T, Maki E. The effect of treatment time and treatment interruption on tumor control following radical radiotherapy of laryngeal cancer. Radiother Oncol 1992;23:137–143.
   PubMed Web of Science ®Google Scholar
• Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992;23:457–467.
   PubMed Web of Science ®Google Scholar
• Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyper-fractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000; 48:7–16.
   PubMed Web of Science ®Google Scholar
• The National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines v2.2013, cervical cancer. Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
   Google Scholar
• Song S, Rudra S, Hasselle MD, Dorn PL, Mell LK, Mundt AJ, et al. The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy. Cancer 2013;119:325–31.
   PubMed Web of Science ®Google Scholar
• Shaverdian N, Gondi V, Sklenar KL, Dunn EF, Petereit DG, Straub MR, et al. Effects of treatment duration during concomitant chemoradiation therapy for cervical cancer. Int J Radiation Bio Phys 2013;86(3):562–568.
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: A powerful initiative to improve cancer care in the United States. Ann Surg Oncol 2008;15(3):683–688.
   PubMed Web of Science ®Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epi 1992;45(6):613–619.
   PubMed Web of Science ®Google Scholar
• Glatting G, Kletting P, Reske SN, Hohl K, Ring C. Choosing the optimal fit function: comparison of the Akaike information criterion and the F-test. Med Phys 2007:34(100):4285–92.
   PubMed Web of Science ®Google Scholar
• Winkleby MA, Jatulis DE, Frank E, Fortmann SP. Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Heath 1992;82(6):816–820.
   PubMed Web of Science ®Google Scholar
• Nishimura Y. Rationale for chemoradiotherapy. Int J Clin Oncol 2004;9:414–420.
   PubMedGoogle Scholar
• Jones B, Dale RG. The potential for mathematical modeling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy. Br J Radiol 2005;78:939–944.
   PubMed Web of Science ®Google Scholar
• Geh JI, Bond SJ, Bentzen SM, Glynne-Jones R. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol 2006;78:236–244.
   PubMed Web of Science ®Google Scholar
• Chen SW, Liang JA, Yang SN, Ko HL, Lin FJ. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy. Radiotherapy and Oncology 2003;67:69–76.
   PubMed Web of Science ®Google Scholar
• Campbell SM, Roland MO, Buetow SA. Defining quality care. Social Science & Med 2000;51:1611–1625.
   PubMed Web of Science ®Google Scholar
• Smith GL, Jiang J, Giordano SH, Meyer LA, Eifel PJ. Trends in the quality of treatment for patients with intact cervical cancer in the United States, 1999 through 2011. Int J Radiation Oncol Biol Phys 2015;92(2):260–267.
   PubMed Web of Science ®Google Scholar
• Lin JF, Berger JL, Krivak TC, Beriwal S, Chan JK, Sukumvanich P, et al. Impact of facility volume on therapy and survival for locally advanced cervical cancer. Gynecol Oncol 2014;132:416–422.
   PubMed Web of Science ®Google Scholar
• American Society of Clinical Oncology. The state of cancer care in America, 2014: a report by the American Society of Clinical Oncology. J Clin Oncol 2014;10(2):119–42.
   Google Scholar
• Quality of Cancer Care Performance Measures. National Quality Forum website. http://www.qualityforum.org/Projects/c-d/Cancer_Care_Phase_II/Cancer_Care_Phase_I-II.aspx. AccessedMarch 28, 2014.
   Google Scholar
• Lazar EJ, Fleischut P, Regan BK. Quality measurement in healthcare. Annu Rev Med 2013;64:485–96.
   PubMed Web of Science ®Google Scholar
• Werner RM, Bradlow ET, Asch DA. Does hospital performance on process measures directly measure high quality care or is it just a marker of unmeasured care? Health Services Research 2008;43(5):1464–1483.
   PubMed Web of Science ®Google Scholar